Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd vs China Biologic Products Inc.
A side-by-side look at two Chinese stocks — live quote, valuation, growth, listing venue, dual-listing and delisting status, and the WealthyTec Rank. A factual comparison for orientation, not investment advice.
| Metric | Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 0874.HK · Hong Kong 15.20 HKD | China Biologic Products Inc. CBPO · US (ADR) 77.56 USD |
|---|---|---|
| Day change | +0.13% | +4.19% |
| Market cap | $3.76B | $2.14B |
| P/E (TTM) | — | — |
| 2y EPS CAGR | — | — |
| WealthyTec Rank | 9.3 | 7.7 |
| Rank within sector | #2 of 31 | #6 of 31 |
| Listing venue | HKEX | NYSE / NASDAQ (ADR) |
| Other listings | n/a | n/a |
| Delisting filings | None on record | None on record |
| Sector | Health Care | Health Care |
| Industry | Biotech and Pharma | Biotech and Pharma |
Of the two, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd currently carries the higher WealthyTec Rank (9.3 vs 7.7). The Rank reflects past revenue, earnings and EPS trends only — not valuation, momentum, or the policy and delisting risks every China investor should weigh, and it is not a recommendation to buy, sell or hold either security. See our rank methodology.